ORAI3 pharmacologic or molecular (siRNA) neutralization inhibits protective GSK3β phosphorylation, impairs early adaptive cardiac hypertrophy and accelerates HF [131]. This evidence concerns the gene ORAI3 and cardiac hypertrophy.